SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010209
Filing Date
2021-08-04
Accepted
2021-08-04 16:11:51
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20210630x10q.htm   iXBRL 10-Q 1563821
2 EX-31.1 ampe-20210630xex31d1.htm EX-31.1 15403
3 EX-31.2 ampe-20210630xex31d2.htm EX-31.2 15390
4 EX-32.1 ampe-20210630xex32d1.htm EX-32.1 8617
5 GRAPHIC ampe-20210630x10q002.jpg GRAPHIC 5204
6 GRAPHIC ampe-20210630x10q003.jpg GRAPHIC 28404
7 GRAPHIC ampe-20210630x10q004.jpg GRAPHIC 73702
  Complete submission text file 0001558370-21-010209.txt   7186877

Data Files

Seq Description Document Type Size
8 EX-101.SCH ampe-20210630.xsd EX-101.SCH 51874
9 EX-101.CAL ampe-20210630_cal.xml EX-101.CAL 41015
10 EX-101.DEF ampe-20210630_def.xml EX-101.DEF 155306
11 EX-101.LAB ampe-20210630_lab.xml EX-101.LAB 363861
12 EX-101.PRE ampe-20210630_pre.xml EX-101.PRE 314761
13 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20210630x10q_htm.xml XML 1458334
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 211144131
SIC: 2834 Pharmaceutical Preparations